TipRanksMassive Job Cuts Send Bristol-Myers Squibb (NYSE:BMY) into Tailspin - TipRanks.comApr 25Steve AndersonBy Steve Andersonmore_vert
Fierce BiotechBMS plans $1.5B in cuts through '25, with 2000-plus layoffsApr 25Max BayerBy Max Bayermore_vert
The Wall Street JournalBristol-Myers Squibb to Cut 2,200 Jobs as Part of $1.5 Billion Cost-Cutting EffortApr 25Jennifer CalfasBy Jennifer Calfasmore_vert
Spectroscopy OnlineBest of the Week: Big Pharma Restructuring, Raman Spectroscopy, Artificial IntelligenceApr 26more_vert
Barron'sBristol Myers Cuts Full-Year Earnings Forecast, Launches Cost CutsApr 25Angela PalumboBy Angela Palumbomore_vert
ScripBMS Will Cut $1.5bn And 2200 Jobs To Reinvest In Needed GrowthApr 25Mandy JacksonBy Mandy Jacksonmore_vert
Yahoo FinanceBeyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)Apr 26more_vert
CoStar GroupPharmaceutical Firm To Close Large San Francisco Research Facility in Consolidation MoveApr 26Pawan NaiduBy Pawan Naidumore_vert
STATBristol Myers Squibb CEO Christopher Boerner outlines plansApr 25Matthew HerperBy Matthew Herpermore_vert
The Wall Street JournalHeard on the Street: Bristol-Myers Goes From Big Pharma to Little PharmaApr 25David WainerBy David Wainermore_vert
Marketscreener.comBristol-Myers Cuts '24 EPS View, Posts Narrower-Than-Seen 1Q LossApr 25Rob CurranBy Rob Curranmore_vert
MarketWatchBristol Myers Squibb shares fall amid sluggish sales of some newer drugsApr 25Eleanor LaiseBy Eleanor Laisemore_vert
BioSpaceBMS Decision to Lay Off 2,200 Employees Comes After M&A Spending SpreeApr 26Greg SlabodkinBy Greg Slabodkinmore_vert
AlphaStreetKey highlights from Bristol Myers Squibb’s (BMY) Q1 2024 earnings resultsApr 25more_vert
Investing.com UKBristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion AcquisitionsApr 25more_vert
BloombergBristol Myers Beats on Revenue as Revlimid Sales Decline SlowsApr 25Ike Swetlitz & Damian GardeBy Ike Swetlitz & Damian Gardemore_vert
BenzingaCrude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results - ATN International (NASDAQ:ATNI), Bristol ...Apr 25Avi KapoorBy Avi Kapoormore_vert
InvestorPlaceBristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job CutsApr 25William WhiteBy William Whitemore_vert
MSNBristol-Myers Earnings Preview: Major near-term headwinds invites worries about Q1 resultsApr 24more_vert
The Motley FoolWhy Bristol Myers Squibb Stock Is Sinking TodayApr 25Keith SpeightsBy Keith Speightsmore_vert
FiercePharmaBristol Myers Squibb leans on long-term growth drivers, strategy overhaul to dodge IRA impactsApr 25Zoey BeckerBy Zoey Beckermore_vert
SaltwireBristol Myers posts quarterly loss, revenue rises 5%Apr 25Deena BeasleyBy Deena Beasleymore_vert
The Business JournalsBristol Myers Squibb to close big Peninsula site, consolidate at another amid company-wide cutsApr 26Ron LeutyBy Ron Leutymore_vert
CNBCBristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly lossApr 25Annika Kim ConstantinoBy Annika Kim Constantinomore_vert
Yahoo FinanceBristol Myers to cut 6% of workforce, trim drug pipelineApr 25Ned PagliaruloBy Ned Pagliarulomore_vert
Yahoo FinanceBristol Myers Squibb stock tumbles on cost-cutting initiativeApr 25Julie HymanBy Julie Hymanmore_vert
Yahoo FinanceWhy Bristol Myers Squibb Stock Is Sinking TodayApr 25Keith SpeightsBy Keith Speightsmore_vert
Yahoo FinanceBristol Myers posts quarterly loss, lays out $1.5 billion cost-saving planApr 25Bhanvi Satija & Deena BeasleyBy Bhanvi Satija & Deena Beasleymore_vert
Yahoo FinanceBristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)Apr 25more_vert
Yahoo FinanceBristol-Myers Squibb Co (BMY) Q1 2024 Earnings Report: A Detailed OverviewApr 25more_vert
BioSpaceBMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1Apr 25Tristan ManalacBy Tristan Manalacmore_vert
Yahoo Finance AustraliaBristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsApr 27more_vert
MarketBeatBristol-Myers Squibb (NYSE:BMY) Trading 1.4% Higher Following Better-Than-Expected EarningsApr 26more_vert
Seeking AlphaBristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off (NYSE:BMY)Apr 25Edmund InghamBy Edmund Inghammore_vert
BenzingaWhy Is Bristol Myers Squibb Stock Trading Lower On Thursday? - Bristol-Myers Squibb (NYSE:BMY)Apr 25Vandana SinghBy Vandana Singhmore_vert
Seeking AlphaBristol-Myers stock drops amid plans to cut jobs (NYSE:BMY)Apr 25Dulan LokuwithanaBy Dulan Lokuwithanamore_vert